Condensed Statements of Cash Flows - USD ($)	8 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2022
Cash flows from operating activities:
Net income (loss)	$ (91,000)	$ 8,497,000
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Payment by Founders of formation costs	5,000	0
Income from cash and investments held in Trust Account	0	(1,216,000)
Change in fair value of warrant liability	0	(7,790,000)
Changes in operating assets and liabilities:
Decrease in prepaid expenses	0	172,000
(Decrease) increase in accounts payable	17,000	(53,000)
Decrease in accrued liabilities and other	0	(24,000)
Net cash used in operating activities	(69,000)	(414,000)
Cash flows from financing activities:
Proceeds from Sponsor Note	200,000	0
Advances from investors	836,000	0
Payment of deferred offering costs	(128,000)	0
Net cash provided by financing activities	908,000	0
Net change in cash	839,000	(414,000)
Cash at beginning of period	0	1,326,000
Cash at end of period	839,000	912,000
Supplemental disclosure of non-cash financing activities:
Sale of 6,468,750 of Class B ordinary shares to Founders and deposited with counsel for formation and deferred offering costs	25,000	0
Payment by Founders of deferred offering costs	20,000	0
Deferred offering costs included in accounts payable and accrued liabilities	345,000	0
Remeasurement of carrying value to redemption value of Class A Ordinary shares subject to redemption	$ 0	$ 1,220,000